Clinical Trial Update: Ilofotase Alfa for Prevention of Renal Damage After Cardiac Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial update on Ilofotase alfa for prevention of acute kidney injury after open-heart surgery; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Ilofotase alfa (Ilofotase alfa)

Snippet

Sponsor: AM-Pharma | Conditions: Open Heart Surgery | Phase 2 | Status: COMPLETED